DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,705,550 | +40.8% | 6,874 | +36.2% | 0.18% | +15.1% |
| Q2 2023 | $1,211,372 | +57.9% | 5,047 | +65.8% | 0.15% | +19.7% |
| Q1 2023 | $767,084 | -3.2% | 3,044 | +2.0% | 0.13% | -12.4% |
| Q4 2022 | $792,396 | +46.7% | 2,985 | +42.8% | 0.14% | +9.8% |
| Q3 2022 | $540,000 | -2.2% | 2,090 | -4.0% | 0.13% | +9.1% |
| Q2 2022 | $552,000 | -14.3% | 2,176 | -1.0% | 0.12% | -9.0% |
| Q1 2022 | $644,000 | +21.5% | 2,197 | +36.4% | 0.13% | +17.7% |
| Q4 2021 | $530,000 | +42.5% | 1,611 | +31.9% | 0.11% | +18.9% |
| Q3 2021 | $372,000 | +17.4% | 1,221 | +3.5% | 0.10% | +10.5% |
| Q2 2021 | $317,000 | +27.3% | 1,180 | +6.6% | 0.09% | -22.5% |
| Q1 2021 | $249,000 | +15.3% | 1,107 | +13.7% | 0.11% | +5.7% |
| Q4 2020 | $216,000 | +4.9% | 974 | +1.8% | 0.10% | -7.9% |
| Q3 2020 | $206,000 | +14.4% | 957 | -6.1% | 0.11% | +18.8% |
| Q2 2020 | $180,000 | +63.6% | 1,019 | +27.7% | 0.10% | +31.5% |
| Q1 2020 | $110,000 | -31.2% | 798 | -23.6% | 0.07% | -25.5% |
| Q4 2019 | $160,000 | – | 1,044 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |